Introduction
============

Amelogenesis imperfecta (AI) is a common group of inherited defects that presentquantitative or qualitative tooth enamel malformation in the absence of systemic manifestations. AI has been classified into syndromic and non-syndromic forms([@B1]). AI is sometimes associated with different syndromes such as tricho-dento-osseous (TDO) syndrome (OMIM \#190320) and cone rod dystrophy. According to population-base studies, the incidence of AI varies, from 1 in 700 to 1 in 15,000 ([@B2]).

The phenotype of affected individuals is highly variable and can be divided based on whether the abnormality results in a reduced amount of enamel (hypoplasia), deficient calcification (hypocalcification), or deficient maturation of the enamel (hypomaturation) ([@B1], [@B3]). The mineralization level of enamel in the hypomaturation and hypocalcified AI is not normal and can be described as hypomineralized. Its genetic inheritance pattern is reported as either an x-linked or autosomal recessive (AR) or autosomal dominant (AD) ([@B3], [@B4]).

In order to better understand how defective enamel formation occurs through development, two fundamental questions must be addressed ([@B1]) which candidate genes are responsible for various forms of AI ([@B2]) and how do these candidate genes and their protein partners work together in normal and abnormal enamel formation? So far, changes in several ameloblast specific genes have been detected including Amelogenin (*AMELX*) ([@B5]--[@B7]), Ameloblastin (*AMBN*) ([@B8], [@B9]), Enamelysin (*ENAM)*([@B10]--[@B17]), Kallikrein-related peptidase-4*KLK4*([@B18], [@B19]),Family with sequence similarity 83 (*FAM83H*) ([@B6], [@B20]--[@B22]) and Matrix Metalloproteinase 20 (*MMP20*)([@B14], [@B23]--[@B25]).

In the present study, we aimed to screen the genetic alterations in the most important candidate genes, *ENAM*, *KLK4*, *MMP20* and *FAM83H* responsible for AI in five Iranian families.

Materials & Methods
===================

Patients
--------

This study was a case study based on genetic testing of affected patients and healthy people Inclusion criteria for our study were as follows: 1) patients were required to have an isolated form of AI; 2) Patients were included in this study with inheritance patterns.

A total of 50 family members (22 affected and 28 unaffected) from five Iranian families were studied. Five Iranian families with AI were diagnosed at the Pediatric Dentistry Department of Tehran University of Medical Sciences (TUMS).

The study was performed with the approval of the Institutional Review Board (IRB) and informed consent was obtained from each patient and controls before genetic testing. The pedigree analysis was carried out using Cyrillic 2.1 software.

Molecular Analysis
------------------

5 ml peripheral blood was collected in test tubes containing 0.5 M EDTA from patients, unaffected members of the family and 100 healthy controls. Then, DNA was extracted using DNGPLUS kit (Cinnagen, Tehran-Iran). The PCR amplification was typically carried out using primer pairs of exon-intron boundaries of *ENAM*, *FAM38H*, *MMP20* and *KLK4* genes ([Table 1](#T1){ref-type="table"}), 0.2U Taq DNA polymerase (Roche, Mannheim, Germany), 10pmole of each primer, 200 μM of each dNTPs, 0.67μl of 50mM MgCl2, 60ng DNA and 2.5 μl of PCR buffer in 25μl of PCR reactions. The PCR conditions included an initial denaturation step for 3 min at 95°C, 30 sec at 95°C, 45 sec at 64°C with a 1°C decrease every second cycle down to 55°C, then 55°C for 14 cycles, 1 min at 72°C for extension, and finally 10 min at 72°C. PCR products were separated on 2% agarose gels and visualized with ethidium bromide. Subsequently, to determine any mutation the PCR product was subjected to direct sequencing (Gene Fanavaran, Iran). Sequence data searches were performed in non-redundant nucleic and protein databases BLAST ([http://www.ncbi.nlm.nih.gov/BLAST)](http://www.ncbi.nlm.nih.gov/BLAST).).

###### 

Primer sequences used in this study

  **Primer**   **Sequence**                       **PCR Product Size(bp)**
  ------------ ---------------------------------- --------------------------
  **ENAM**                                        
  EN1F         5′-CTGTGCCAAGCTTTCTGACA-3′         923
  EN1R         5′-TGTTTGGCCCTCTCAAGTGT-3′         
  EN45F        5′-CCCCATCCATTTCCATACTC-3′         523
  EN45R        5′-TGATGGCTGGGGAAATTACT-3′         
  EN6F         5′-TCAGAAATTTTTACACTGGGAAG-3′      323
  EN6R         5′-TGTGAGAGGATAGGGGCAAT-3′         
  EN7F         5′-GAGGATGGAGACAGCCTGAA-3′         302
  EN7R         5′-CGGGCTGAGGTTGATTATGT-3′         
  EN8F         5′-GGGAGATGTAGACTCCCAAGTTT-3′      307
  EN8R         5′-TGATGCACTGGTTTTGTTTCA-3′        
  EN9F         5′-GATCCAGCTGAAGCCTTTGT-3′         324
  **MMP20**                                       
  M1F          5′-CAGGACCTGGAGGAACAACT-3′         201
  M1R          5′-CCAGACACCAATCTAGGTGGA-3′        
  M2F          5′-CCCTGCCTTACCTGAGCAT-3′          470
  M2R          5′-GCCTGACGGATGGATGTAAA-3′         
  M3F          5′-CCGGATTATCCCAACTGTCT-3′         472
  M3R          5′-ACTGTGCGAAGGAGGAGTGT-3′         
  M4F          5′-TGTCAATGCTACTCAAAATGTCC-3′      312
  M5F          5′-AGTTAGGAGAAGGAGATGGG-3′         193
  M5R          5′-CTGATGGGTCTGTGGAATG-3′          
  M6F          5′-CATGTCCAGCGTGAAAGTGT-3′         300
  M6R          5′-GTCTGGGAGTGGAGATGAGG-3′         
  M7F          5′-AGTAAGCAGTGCCCCTCTC-3′          266
  M7R          5′-AAACAAGGCAAGGCAAGG-3′           
  **KLK4**                                        
  K1F          5′-GAGTTGAGGCAGCCTGAGAG-3′         1000
  K1R          5′-ACAAGGAGTTGCAGGGACAC-3′         
  K2F          5′-CTGCTCCTGAACCTCTGACC-3′         615
  K2R          5′-ATTCCCATCCCCATCTCCTA-3′         
  K3F          5′-TGACTGCTCCTGAACCTCTG -3′        149
  K3R          5′-CCTCGCCGTTTATGATTTG-3′          
  K4F          5′-GGGGTTGAAGATGAGAATGG-3′         615
  K4R          5′GGCCCTGTGTGTCTCTGTCT-3′          
  K7F          5′-AAACTGACCTGCCCTCCGT-3′          195
  K7R          5′-TGTCAGACTCGGACACGGA-3′          
  **FAM83H**                                      
  FAM83PF1     5′-CTCGCCAGGAGCCCTTGTCCTGTAGA-3′   486
  FAM83PR1     5′-GGAAGGCCGACAGGAAGT-3′           
  FAM83PF2     5′-CCCTTCTCCTTCCCTAAACG-3′         523
  FAM83PR2     5′-CGCCCAGGGTGAAGTCAT-3′           
  FAM83PF3     5′- CTACCAGCAGCAGTACCAGTG-3′       652
  FAM83PR3     5′- CGAGCGGAATGAGTCCTG-3′          
  FAM83PF4     5′- GCCTTCCCCACCAAGGTC-3′          497
  FAM83PR4     5′- CTGCTGTGCAAAGGAGTCG-3′         
  FAM83PF5     5′- GTTGCCAGCCACAGCAAG-3′          566
  FAM83PR5     5′- GACTCCCCGGAGATGGTAAG-3′        
  FAM83PF6     5′- CAGGATTTATCGAGCAGAAGG-3′       593
  FAM83PR6     5′- GGCTGAACACTTGTCCTTGTC-3′       
  FAM83PF7     5′- AAGGCCATTCTGGAGCAGAT-3′        689
  FAM83PR7     5′- GACGGTGCAGAGATGAAGGT-3′        

Results
=======

Clinical descriptions and mutational analysis
---------------------------------------------

After clinical examination, affected individuals from one family showed clinical features consistent with ADHCAI ([Fig. 1](#F1){ref-type="fig"}), while 4 consanguineous families with 18 affected members were diagnosed for ARHPAI. All affected individuals were clinically and radiographically examined and showed no signs of syndromic conditions or systemic illnesses associated with enamel malformation. In addition, dental examination of the unaffected members showed no evidence of any enamel defect and any syndromic signs.

![Pedigree analysis, Clinical Characterizations and Molecular Study of Family 1 Affected with ADHCAI.A. (A) The pedigree of the family represents an autosomal dominant pattern of inheritance with four affected patients. (B) Phenotype demonstrating hypocalcified amoelogenesis imperfecta. (C) Radiographic examination shows lack of tooth enamel in proband. (D) Chromatogram from wild type *FAM83H* gene. (E) DNA sequencing revealed heterozygous in codon 342 for amino acid serine to threonine (c.1150T\>A, p. Ser 342Thr).Arrows indicate the proband and base subsituation](IJPH-43-1680f1){#F1}

The ADHCAI individuals were typically characterized by soft enamel, which wears off the tooth soon after eruption and following exposure to mastication forces. As it is shown in [Fig. 1C](#F1){ref-type="fig"} enamel cannot be distinguished from dentin by its opacity on radiographs; however, ARHPAI patients presented reduced enamel and spacing between teeth.

Mutation screening in ADHCAI-affected members revealed one novel non-synonymous single-nucleotide substitution in the *FAM83H* gene. This mutation was detected in codon 342 for amino acid serine to threonine (c.1150T\>A, p. Ser 342Thr, [Fig. 1E](#F1){ref-type="fig"})

The mutation was identified in the affected members of the families with ADHCAI, but not in the unaffected individuals as well as in 100 healthy controls, indicating that this genetic change is not common variant in the Iranian populations. [Figure 2](#F2){ref-type="fig"} indicates the positions of mutations identified in the *FAM83H* gene.

![Diagram of the *FAM83H* based on the human sequence. The human *FAM83H* gene is composed of five exons (orange boxes) and four introns (blue line). The 5'-UTR (untranslated regions) and 3'-UTR regions are indicated with black boxes. Arrows show the location of identified missense mutations in the C-terminal sequences](IJPH-43-1680f2){#F2}

Moreover, although no significant mutations in *ENAM, KLK4* and *MMP20* genes were detected in any probands, different polymorphisms were identified within non-coding or/and coding region sequences of these genes ([Table 2](#T2){ref-type="table"}).

###### 

Identified single Nucleotide Polymorphisms (SNPs) in this study

  **Gene**   **Site of Variation**   **gDNA**       **cDNA**    **Protein**          **AI Phenotype**
  ---------- ----------------------- -------------- ----------- -------------------- ------------------
  FAM83H     Exon5                   g.10061G\>A    c.846G\>A   GCG\>GCA(Ala\>Ala)   RHPAI
  FAM83H     Intron4                 g.9945G\>C     \-          \-                   ADHCAI
  KLK4       Exon2                   g.6329G\>T     c.66G\>T    TCG\>TCT(Ser\>Ser)   ARHPAI
  KLK4       Intron1                 g.5193C\>G     \-          \-                   ARHPAI
  ENAM       Intron7                 g.8232T\>G     \-          \-                   ARHPAI
  ENAM       Intron7                 g.8562A\>T     \-          \-                   ARHPAI
  MMP20      Intron5                 g.18514T\>C    \-          \-                   ARHPAI
  MMP20      Intron5                 g.18505A\> G   \-          \-                   ARHPAI

Discussion
==========

In this study, we performed direct PCR sequencing for 5 families having at least two affected individuals with AI. ARHPAI was diagnosed in 4 out of 5 families. The clinical features of hypoplastic AI in our patients were typically yellow-brown discoloration of the teeth and evidence of pathological enamel loss during wear as well as fracturing. One family was diagnosed for ADHCAI. The clinical characteristics of ADHPCAI usually presented with yellow-brown teeth discoloration and poorly mineralized enamel that have increased enamel proteins.

Our mutation screening within coding sequences of three AI candidate genes including *KLK4*, *ENAM* and *MMP20* failed to detect any mutation in affected patients. However, several single nucleotide polymorphisms were found in the studied samples. In agreement with our results, several studies could not detect any mutation in the aforementioned genes involved in enamel defects in different populations ([@B14], [@B15], [@B26]). Ghandehari et al. studied the mutations in *MMP20, ENAM* and *KLK4* genes in Iranian families with generalized hypoplastic phenotypes; however, no mutations were detected in their samples ([@B27]). In addition, another study by Kim et al. in 24 families with non-syndromic enamel defects found only a few disease-causing mutations ([@B14]). These results strongly suggested that several genes and loci might be associated with AI.

Although we were not able to identify any relevant mutation in the hypoplastic AI patients, one novel missense mutation in the *FAM83H* gene, c.1150T\>A, p. Ser 342Thr was detected in the ADHPCAI patients. The mutation was co-segregated among affected members of families with the disease phenotype but not in those that were unaffected. Mutations in the candidate genes, *FAM83H*, *KLK4*, *MMP20* and *ENAM* have been suggested to be important in the etiology of AI ([@B19], [@B21], [@B28]). Even though our results are the first report that demonstrates the genetic alterations of *FAM83H* in Iranian patients, several mutations within this gene have been identified in AI patients in different ethnic groups ([@B20]--[@B22], [@B29]--[@B33]). Kim et al. ([@B21]) studied two families with autosomal-dominant hypocalcified AI and identified nonsense mutations (R325X and Q398X) in the *FAM83H* gene. In addition, a study previously described two nonsense transition mutations in a single allele of *FAM83H* (c.1379G\>A; g.5663G\>A in the C-terminal exon 5) in the Chinese population ([@B34]). More recently, Wang et al. identified disease-causing mutations (g.6930delG; c.245delG; p.Gly82Alafs\*87) in their samples ([@B19]). Up to now, the majority of genetic alterations (∼14 mutations) have been reported in the last exon of *FAM83H*, which encodes the C-terminal region.

According to our findings as well as the literature published so far, two main questions needed to be addressed namely: 1) Which parts of this gene induces more pathogenic effects and 2) How can we define the molecular characterization of the *FAM83H* gene? To address the first question, as early pointed out, all disease-causing mutations in *FAM83H* are located within exon 5. Therefore, it seems that this part of *FAM83H* gene could be the hotspot for genetic alterations. In order to address the second question, several molecular studies such as sub-cellular localization, using knockout mice experiments and bioinformatics strategies are required. It is believed that investigating biological functions of the genetic variations provide a great opportunity for understanding molecular bases of human diseases. Even though some features and their predicted functions of human FAM83H have been previously reported the C-terminal region function(s) was not adequately analyzed ([@B34]). It has been suggested the implication of FAM83H protein in normal and abnormal functions through either direct or indirect interactions with several protein partners.

Conclusion
==========

Our findings indicated an association between AI and *FAM83H* mutations. However, the exact mechanism(s) by which this gene acts in the pathogenesis of AI remains to be clarified. To define direct or indirect influences of FAM83H on normal and abnormal enamel formation different techniques such as chromatin immunoprecipitation assay (ChIP Assay) and protein-protein interaction using specific antibodies may be useful strategies for identification of its down-stream target signaling pathways.
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